Mistaken diagnoses of Hodgkin's disease

Hematology/Oncology Clinics of North America

Volumn 11, Issue 5, 1997, Pages 863-892

  Braziel, R M ^a   Oyama, K ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER DIAGNOSIS; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; PRIORITY JOURNAL; REVIEW;

EID: 0030885561     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70467-6     Document Type: Article

References (58)

1. S.L. Abbondanzo N. Sato S.E. Straus Acute infectious mononucleosis. CD30 (Ki-1) antigen expression and histologic correlations Am J Clin Pathol 93 1990 698
2. M.A. Bitter W.A. Franklin R.A. Larson Morphology in Ki-1 (CD30)–positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35) Am J Surg Pathol 14 1990 305
3. B.F. Burns T.V. Colby R.F. Dorfman Differential diagnostic features of nodular L & H Hodgkin's disease, including progressive transformation of germinal centers Am J Surg Pathol 8 1984 253
4. T.T. Casey J.B. Cousar M. Mangum Monomorphic lymphomas arising in patients with Hodgkin's disease: Correlation of morphologic, immunophenotypic, and molecular genetic findings in 12 cases Am J Pathol 136 1990 81
5. N. Chelloul J. Burke R. Motteram Histocompatibility Testing 1972 Munksgaard Copenhagen 769 771
6. S.M. Chittal P. Brousset J.-J. Voigt Large B cell lymphoma rich in T-cells and simulating Hodgkin's disease Histopathology 19 1991 211
7. A. Chott K. Kaserer I. Augustin Ki-1 positive large cell lymphoma. A clinicopathologic study of 41 cases Am J Surg Pathol 14 1990 439
8. H. Daus L. Trumper J. Roth Hodgkin and Reed-Sternberg cells do not carry T-cell receptor γ gene rearrangements: Evidence from single-cell polymerase chain reaction examination Blood 85 1995 1590
9. J. Delabie A. Tierens G. Wu Lymphocyte predominance in Hodgkin's disease: Lineage and clonality determination using a single-cell assay Blood 84 1994 3291
10. B. Falini L. Flenghi L. Fedeli In vivo targeting of Hodgkin and Reed-Sternberg cells of Hodgkin's disease with monoclonal antibody Ber-H2 (CD30): Immunohistological evidence Br J Hematol 82 1992 38
11. B. Falini S. Pileri G. Pizzolo CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy Blood 85 1995 1
12. J.A. Ferry R.M. Linggood K.M. Convery Hodgkin disease, nodular sclerosis type Cancer 71 1993 457
13. S.L. Glaser W.G. Swartz Time trends in Hodgkin's disease incidence: The role of diagnostic accuracy Cancer 66 1990 2196
14. S. Gledhill A. Krajewski A.E. Dewar Analysis of T-cell receptor and immunoglobulin gene rearrangements in the diagnosis of Hodgkin's and non-Hodgkin's lymphoma J Pathol 161 1990 245
15. T.M. Grogan C. Kjeldsberg R. Tubbs A Southwest Oncology Group (SWOG) clinical analysis of anaplastic large cell lymphoma (ALCL) in the revised European American lymphoma (REAL) classification [abstract 644] Mod Pathol 8 1995 111A
16. D.M. Grossman C.A. Hanson B. Schnitzer Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma Am J Surg Pathol 15 1991 668
17. F.G. Haluska A.M. Brukfsky G.P. Canellos The cellular biology of the Reed-Sternberg cell Blood 84 1994 1005
18. M.L. Hansmann H. Stein C. Fellbaum Nodular paragranuloma can transform into high grade malignant lymphoma of B type Hum Pathol 20 1989 1169
19. M.L. Hansmann C. Fellbaum P.K. Hui Progressive transformation of germinal centers with and without association to Hodgkin's disease Am J Clin Pathol 93 1990 219
20. N.L. Harris E.S. Jaffe H. Stein A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group Blood 84 1994 1361
21. T. Hodgkin On some morbid appearances of the absorbent glands and spleen Med Chir Trans 17 1832 68
22. R.T. Hoppe A.L. Hanlon G.E. Hanks Progress in the treatment of Hodgkin's disease in the United States, 1973–1983: The patterns of care study Cancer 74 1994 3198
23. O.W. Kamel L.M. Weiss M. van de Rijn Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy Am J Surg Pathol 20 1996 1279
24. J.A. Kant S.M. Hubbard D.L. Longo The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease J Clin Oncol 4 1986 284
25. H.S. Kaplan Hodgkin's disease: Unfolding concepts concerning its nature, management and prognosis Cancer 45 1980 2439
26. J. Krishnan K. Wallberg G. Frizzera T-cell–rich large B-cell lymphoma. A study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness Am J Surg Pathol 18 1994 455
27. R. Kueppers K. Rajewski M. Zhao Hodgkin's disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development Proc Natl Acad Sci USA 91 1994 10962
28. L. Lamant F. Meggetto T.A. Saati High incidence of the t(2; (5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining Blood 87 1996 284
29. R.J. Lukes J.J. Butler The pathology and nomenclature of Hodgkin's disease Cancer Res 26 1966 1063
30. K.A. Maclennan M.H. Bennett A. Tu Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease Cancer 64 1989 1686
31. W.R. Macon M.E. Williams J.P. Greer T-cell-rich B-cell lymphomas: A clinicopathologic study of 19 cases Am J Surg Pathol 16 1992 351
32. D.Y. Mason P.M. Banks J. Chan Nodular lymphocyte predominance Hodgkin's disease: A distinct clinicopathological entity Am J Surg Pathol 18 1994 526
33. J.A. McBride J. Rodriguez R. Luthra T-cell–rich B large-cell lymphoma simulating lymphocyte rich Hodgkin's disease Am J Surg Pathol 20 1996 193
34. P.A. McKinney F.E. Alexander T.J. Ricketts on behalf of the Leukemia Research Fund Data Collection Study Group A specialist leukemia/lymphoma registry in the UK: Part 1. Incidence and geographical distribution of Hodgkin's disease Br J Cancer 60 1989 942
35. T.P. Miller G.E. Byrne S.E. Jones Mistaken clinical and pathologic diagnoses of Hodgkin's disease: A Southwest Oncology Group study Cancer Treat Rep 66 1982 645
36. M. Miettenen K.O. Franssila E. Saxen Hodgkin's disease, lymphocytic predominance nodular: Increased risk for subsequent non-Hodgkin's lymphomas Cancer 51 1983 2293
37. G.T. O'Conor P. Correa B. Christine Hodgkin's disease in Connecticut: Histology and age distribution Natl Cancer Inst Monogr 36 1973 3
38. B.M. Osborne Contextual diagnosis of Hodgkin's disease and non-Hodgkin's lymphoma Radiol Clin North Am 28 1990 669
39. B.M. Osborne J.J. Butler Clinical implications of progressive transformation of germinal centers Am J Surg Pathol 8 1984 725
40. B.M. Osborne J.J. Butler W.C. Pugh The value of immunophenotyping on paraffin sections in the identification of T-cell rich B-cell large-cell lymphomas: Lineage confirmed by JH rearrangement Am J Surg Pathol 14 1990 933
41. G. Pallesen S.J.K. Hamilton-Dutoit Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma Am J Pathol 133 1988 446
42. L.X. Pan T.C. Diss H.Z. Peng Nodular lymphocyte predominance Hodgkin's disease: A monoclonal or polyclonal B-cell disorder? Blood 87 1996 2428
43. E. Patsouris H. Noel K. Lennert Cytohistologic and immunohistochemical findings in Hodgkin's disease, mixed cellularity type, with a high content of epithelioid cells Am J Surg Pathol 13 1989 1014
44. S. Pileri M. Bocchia C.D. Baroni Anaplastic large cell lymphoma (CD30+/Ki-1+): Results of a prospective clinico-pathological study of 69 cases Br J Hematology 86 1994 513
45. R.J. Prescott S. Wells D.L. Bisset Audit of tumor histopathology reviewed by a regional oncology centre J Clin Pathol 48 1995 245
46. A.D. Ramsay W.J. Smith P.G. Isaacson T-cell–rich B-cell lymphoma Am J Surg Pathol 12 1988 433
47. T.A. Saati J. Tkaczuk G. Krissansen A novel antigen detected by the CBF.78 antibody further distinguishes anaplastic large cell lymphoma from Hodgkin's disease Blood 86 1995 2741
48. T. Sandlund C.-H. Pui V. Santana Clinical features and treatment for children with CD30+ large-cell non-Hodgkin's lymphoma J Clin Oncol 12 1994 895
49. A.H. Sarris R. Luthra V. Papadimitracopoulou Amplification of genomic DNA demonstrates the presence of the t(2;5)(p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis Blood 88 1996 1771
50. D.T. Silverman P. Correa G.T. O'Conor A comparison of Hodgkin's disease in Alameda County, California, and Connecticut: Histologic subtype and age distribution Cancer 39 1977 1758
51. H. Stein D.Y. Mason J. Gerdes The expression of the Hodgkin's disease–associated antigen Ki-1 in reactive and neoplastic lymphoid tissue. Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells Blood 66 1985 848
52. J.T. Sundeen J. Cossman E.S. Jaffe Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent “large cell lymphoma”: Histologic progression or composite malignancy Am J Surg Pathol 12 1988 599
53. W.S.C. Symmers Survey of the eventual diagnosis in 600 cases referred for a second histologic opinion after an initial biopsy diagnosis of Hodgkin's disease J Clin Pathol 21 1968 650
54. P. Tosi L. Leoncine T.M. Del Vecchio Phenotypic overlaps between pleomorphic malignant T-cell lymphomas and mixed-cellularity Hodgkin's disease Int J Cancer 52 1992 202
55. L.M. Weiss F.R. Lopategue L.H. Sun Absence of the t(2;5) in Hodgkin's disease Blood 85 1995 2845
56. R.S. Wickert D.D. Weisenburger A. Tierens Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B-lineage Blood 86 1995 2312
57. T.J. Wijlhuizen L.W. Vrints R. Jairam Grades of nodular sclerosis (NSI-NSII) in Hodgkin's disease: Are they of independent prognostic value? Cancer 63 1989 1150
58. G.S. Wood D.L. Hardman R. Boni Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease Blood 88 1996 1765 1770